Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Petros Pharmaceuticals, Inc. (PTPI)

PNK · Drug Manufacturers - Specialty & Generic

$0.000.00 (0.00%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$169,489
P/E (TTM)
0.00
EPS
$6.64
Div Yield
52W Range
$0.00–$0.03
Beta
1.87

Company overview

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

3 employeespetrospharma.com

Peers in Healthcare

Petros Pharmaceuticals, Inc. has no peer companies in this window.

Recent press releases

Petros Pharmaceuticals, Inc. has not issued a press release in this window.

SEC filings

All filings →

Petros Pharmaceuticals, Inc. has not filed an SEC document in this window.

Petros Pharmaceuticals, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2023-12-31 · prior 2023-03-31
4,286 sh● NEW

People at Petros Pharmaceuticals, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
NI -$2.3M
06/25
NI $5.4M
09/25
NI -$922.7K
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.03
Prior: $-1.29
Revenue sparkline